ArticleEuropean journal of clinical pharmacology2014

Risk of intracranial haemorrhage in patients with atrial fibrillation treated with novel oral anticoagulants: testing the equivalence margins between dabigratran, rivaroxaban and apixaban.

Andrea Messori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.